Surprise! Novo Nordisk's Wegovy Just Achieved Another Milestone. Here's What You Need to Know.The Motley Fool • 06/30/24
Novo Nordisk stops the ocedurenone CLARION-CKD trial and recognises impairment lossGlobeNewsWire • 06/26/24
Wegovy Approved In China—But Novo Nordisk Promises Existing Patients Priority Amid ShortagesForbes • 06/25/24
Novo Nordisk announces 4.1 billion USD investment to expand US manufacturing capacity adlineGlobeNewsWire • 06/24/24
Novo Nordisk to build $4.1 billion North Carolina facility to boost output of Wegovy, OzempicCNBC • 06/24/24